Published in Pigment Cell Melanoma Res on May 01, 2016
Highly recurrent TERT promoter mutations in human melanoma. Science (2013) 8.40
TERT promoter mutations in familial and sporadic melanoma. Science (2013) 7.82
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A (2013) 6.88
Genomic Classification of Cutaneous Melanoma. Cell (2015) 3.91
Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science (2015) 2.37
Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science (2015) 1.91
Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma. Nat Commun (2014) 1.39
Cancer-associated TERT promoter mutations abrogate telomerase silencing. Elife (2015) 1.28
Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation. Nat Cell Biol (2015) 1.18
The genomic landscape of childhood and adolescent melanoma. J Invest Dermatol (2014) 0.99
TERT promoter mutations and telomere length in adult malignant gliomas and recurrences. Oncotarget (2015) 0.96
Telomerase Expression by Aberrant Methylation of the TERT Promoter in Melanoma Arising in Giant Congenital Nevi. J Invest Dermatol (2016) 0.83
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system. Mol Oncol (2014) 0.90
Shedding light on inflammatory pseudotumor in children: spotlight on inflammatory myofibroblastic tumor. Pediatr Radiol (2015) 0.82
Initial diagnostic management of pediatric bone tumors. J Pediatr Surg (2016) 0.75
SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor. Cancer Genet (2014) 0.75